Jefferies Initiates Coverage On City Therapeutics with Buy Rating, Announces Price Target of $32

Benzinga · 2d ago
Jefferies analyst Maury Raycroft initiates coverage on City Therapeutics (NASDAQ:CTY) with a Buy rating and announces Price Target of $32.